Ferring Pharmaceuticals News and Resources

Ferring Pharmaceuticals has secured a long-term supplier for its bladder cancer gene therapy, Adstiladrin. The company has entered into an agreement with SK pharmteco, who will be responsible for the manufacture, testing, and release of the medicine. The partnership comes after